Physician

Adam Louis Rothman, MD

According to 2025 Medicare claims, Adam Rothman, MD (NPI: 1407234461) practices ophthalmology in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is UNIVERSITY OF MIAMI (NPI: 1780621953; TIN: 592579938) and primary practice location at 33324-3279.

Rothman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 458 traditional Medicare patients, billed 1,625 HCPCS/CPT codes, and received $104,138 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,375 prescription claims across 727 beneficiaries totaling $275,649 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 1 records totaling $143. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $3,077 to $104,138. Similarly, Part D prescription costs have risen steadily, from $13,792 to $275,649. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$61K$122K2019 Medicare payment: $3,077 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $17,341 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $67,287 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $104,265 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $121,610 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $104,138 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20196466$3,077
2020148345$17,341
20212981,016$67,287
20224431,606$104,265
20234581,745$121,610
20244581,625$104,138

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$160K$319K2015 Drug cost: $13,792 (USD; Tot_Drug_Cst)2016 Drug cost: $30,892 (USD; Tot_Drug_Cst)2017 Drug cost: $3,502 (USD; Tot_Drug_Cst)2018 Drug cost: $1,563 (USD; Tot_Drug_Cst)2019 Drug cost: $12,497 (USD; Tot_Drug_Cst)2020 Drug cost: $73,552 (USD; Tot_Drug_Cst)2021 Drug cost: $149,921 (USD; Tot_Drug_Cst)2022 Drug cost: $255,171 (USD; Tot_Drug_Cst)2023 Drug cost: $319,296 (USD; Tot_Drug_Cst)2024 Drug cost: $275,649 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201554235$13,792
201679518$30,892
20173179$3,502
20181127$1,563
201966123$12,497
2020182619$73,552
20212921,532$149,921
20224722,641$255,171
20235833,692$319,296
20247274,375$275,649

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more292532$67
92083Exam of visual field with extended testing252284$18
92133Imaging of optic nerve190196$15
92020Exam of the internal drainage system of eye9698$14
76514Ultrasound scan of cornea to determine thickness9292$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost954,431$44,303
MethazolamideMethazolamide1055,044$26,776
RhopressaNetarsudil Mesylate461,994$24,116
Prednisolone AcetatePrednisolone Acetate36713,807$19,207
Alphagan PBrimonidine Tartrate462,028$16,152

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$143Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Louis Rothman, MD?

Tedicare shows public-source Medicare data for Adam Louis Rothman, MD (NPI 1407234461), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Louis Rothman, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Louis Rothman, MD?

Adam Louis Rothman, MD is linked to UNIVERSITY OF MIAMI (billing NPI 1780621953) in the available physician profile data.

Does Adam Louis Rothman, MD have Open Payments data?

Adam Louis Rothman, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.